# A Phase I Clinical Trial of Meplazumab in Healthy Volunteer

> **NCT04369586** · PHASE1 · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 59 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** meplazumab for injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04369586
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-25
- **Primary completion:** 2020-08-18
- **Final completion:** 2020-11-20
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2021-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04369586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04369586, "A Phase I Clinical Trial of Meplazumab in Healthy Volunteer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04369586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*